Moomoo AIのまとめ
On December 31, 2023, Viking Global Investors LP and related entities and individuals, including Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott, and Rose S. Shabet (collectively referred to as the Reporting Persons), filed an amendment to their Schedule 13G with the SEC, disclosing an 8.8% ownership stake in Ginkgo Bioworks Holdings, Inc. This stake amounts to 143,085,126 shares of Class A common stock. The filing indicates that the shares are beneficially owned and that the Reporting Persons have shared voting and dispositive power over these shares. The ownership percentage is based on 1,619,442,071 shares of Common Stock outstanding as of October 31, 2023, as reported by Ginkgo Bioworks in its quarterly report. The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, indicating that the shares were not acquired with the purpose or effect of changing or influencing the control of the issuer.
On December 31, 2023, Viking Global Investors LP and related entities and individuals, including Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott, and Rose S. Shabet (collectively referred to as the Reporting Persons), filed an amendment to their Schedule 13G with the SEC, disclosing an 8.8% ownership stake in Ginkgo Bioworks Holdings, Inc. This stake amounts to 143,085,126 shares of Class A common stock. The filing indicates that the shares are beneficially owned and that the Reporting Persons have shared voting and dispositive power over these shares. The ownership percentage is based on 1,619,442,071 shares of Common Stock outstanding as of October 31, 2023, as reported by Ginkgo Bioworks in its quarterly report. The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, indicating that the shares were not acquired with the purpose or effect of changing or influencing the control of the issuer.
2023年12月31日、Viking Global Investors LPおよび関連事業体や個人、Viking Global Opportunities Parent GP LLC、Viking Global Opportunities GP LLC、Viking Global Opportunities Portfolio GP LLC、Viking Global Opportunities Illiquid Investments Sub-Master LP、O. Andreas Halvorsen、David C. Ott、およびRose S. Shabet（以下、報告書提出者と総称）...すべて展開
2023年12月31日、Viking Global Investors LPおよび関連事業体や個人、Viking Global Opportunities Parent GP LLC、Viking Global Opportunities GP LLC、Viking Global Opportunities Portfolio GP LLC、Viking Global Opportunities Illiquid Investments Sub-Master LP、O. Andreas Halvorsen、David C. Ott、およびRose S. Shabet（以下、報告書提出者と総称）は、SECに対してスケジュール13Gの改訂申請を提出し、Ginkgo Bioworks Holdings, Inc.に対して8.8％の所有権を握っていることを公表しました。この所有権は、Class A普通株式の143,085,126株に相当します。申請書によれば、これらの株式は有益所有され、報告書提出者はこれらの株式について共同の投票および処分権を有しています。所有割合は、Ginkgo Bioworksが四半期報告書で報告した2023年10月31日現在の普通株式1,619,442,071株に基づいています。この申請書は、証券取引法13d-1（c）条に基づいて作成され、これらの株式が発行体の支配を変更または影響を与える目的および効果をもって取得されたものではないことを示しています。
役に立った
役に立たない